FJ Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FJ Pharma
Largest movements
- Receivables within one year +€11,443
up €11,443 (+109.5%), from €10,451 to €21,894
of which Trade receivables: +€9,281
- Cash -€6,903
down €6,903 (-15.3%), from €44,979 to €38,076
mainly Receivables within one year (-€11,443) and Tax, wage and social debts (-€5,105)
- Tangible fixed assets -€2,195
down €2,195 (-25.4%), from €8,627 to €6,432
- Reserves +€7,202
up €7,202 (+18.6%), from €38,772 to €45,974
- Tax, wage and social debts -€5,105
down €5,105 (-50.7%), from €10,062 to €4,957
- Gross operating margin -€2,186
down €2,186 (-13.8%), from €15,871 to €13,684
- Taxes -€734
down €734 (-20.2%), from €3,643 to €2,909
- Depreciation +€733
up €733 (+50.2%), from €1,461 to €2,195
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €64,108 | €66,403 | +€2,295 | +3.6% |
| Fixed assets | 21/28 | €8,627 | €6,432 | -€2,195 | -25.4% |
| Tangible fixed assets | 22/27 | €8,627 | €6,432 | -€2,195 | -25.4% |
| Furniture and vehicles | 24 | €8,627 | €6,432 | -€2,195 | -25.4% |
| Current assets | 29/58 | €55,481 | €59,970 | +€4,489 | +8.1% |
| Amounts receivable within one year | 40/41 | €10,451 | €21,894 | +€11,443 | +109.5% |
| Trade receivables | 40 | €9,983 | €19,263 | +€9,281 | +93.0% |
| Other amounts receivable | 41 | €468 | €2,631 | +€2,163 | +461.8% |
| Cash at bank and in hand | 54/58 | €44,979 | €38,076 | -€6,903 | -15.3% |
| Deferred charges and accrued income | 490/1 | €51 | €0 | -€51 | -100.0% |
| Total equity and liabilities | 10/49 | €64,108 | €66,403 | +€2,295 | +3.6% |
| Equity | 10/15 | €41,772 | €48,974 | +€7,202 | +17.2% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €38,772 | €45,974 | +€7,202 | +18.6% |
| Distributable reserves | 133 | €38,772 | €45,974 | +€7,202 | +18.6% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €22,336 | €17,429 | -€4,907 | -22.0% |
| Amounts payable within one year | 42/48 | €22,271 | €17,429 | -€4,842 | -21.7% |
| Trade debts | 44 | €2,108 | €2,101 | -€7 | -0.3% |
| Suppliers | 440/4 | €2,108 | €2,101 | -€7 | -0.3% |
| Taxes, remuneration and social security | 45 | €10,062 | €4,957 | -€5,105 | -50.7% |
| Taxes | 450/3 | €10,062 | €4,957 | -€5,105 | -50.7% |
| Other amounts payable | 47/48 | €10,101 | €10,372 | +€271 | +2.7% |
| Accrued charges and deferred income | 492/3 | €66 | €0 | -€66 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,461 | €2,195 | +€733 | +50.2% |
| Other operating charges | 640/8 | €515 | €396 | -€119 | -23.1% |
| Non-recurring operating charges | 66A | €217 | €0 | -€217 | -100.0% |
| Gross operating margin | 9900 | €15,871 | €13,684 | -€2,186 | -13.8% |
| Operating profit (loss) | 9901 | €13,678 | €11,094 | -€2,584 | -18.9% |
| Financial income | 75/76B | €0 | €0 | +€0 | |
| Recurring financial income | 75 | €0 | €0 | +€0 | |
| Financial charges | 65/66B | €228 | €150 | -€78 | -34.3% |
| Recurring financial charges | 65 | €228 | €150 | -€78 | -34.3% |
| Profit (loss) for the period before taxes | 9903 | €13,449 | €10,944 | -€2,506 | -18.6% |
| Income taxes | 67/77 | €3,643 | €2,909 | -€734 | -20.2% |
| Profit (loss) for the period | 9904 | €9,806 | €8,035 | -€1,771 | -18.1% |
| Profit (loss) for the period to be appropriated | 9905 | €9,806 | €8,035 | -€1,771 | -18.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.